The Europe digestive health supplements market is expected to reach USD 7.07 billion by 2030 and is anticipated to grow at a CAGR of 8.5% from 2024 to 2030. The rising prevalence of digestive issues can be attributed to sedentary lifestyles, adopting Western diets rich in processed foods, and the increasing stressors of modern life. It includes conditions such as Irritable Bowel Syndrome (IBS), Inflammatory Bowel Diseases (IBD), acid reflux, and functional dyspepsia, which have become increasingly common and are affecting a significant portion of the European population.
According to a report by United European Gastroenterology (UEG) in 2023, Gastrointestinal (GI) and liver disorders have a significant impact on the people of Europe, causing nearly one million deaths each year across all age groups. These conditions are associated with morbidity and healthcare expenses. The incidence and prevalence of many GI disorders are highest among the young and elderly, and as Europe's population ages, the disease burden is expected to increase.
The European region is home to over 332 million individuals affected by digestive disorders. In 31 countries with available data, digestive disease-related morbidity results in a loss of output equal to 0.22% of GDP, while premature mortality accounts for 0.25%. The report suggests that reducing digestive disease-related premature deaths by 25% in 2019 could have prevented productivity losses worth EURO 11.4 billion in 31 countries.
The European digestive health supplement market is influenced by the increasing awareness of the gut microbiome's role in weight regulation. The gut microbiome extracts energy from food, regulates metabolism, and stores and distributes fat. As a result, digestive health supplements, particularly those enriched with probiotics, are becoming crucial tools in addressing this awareness. Probiotics are live microorganisms, often beneficial bacteria that offer health benefits when consumed in sufficient quantities. In the context of weight regulation, specific probiotic strains have been linked to positive changes in gut microbiota composition, affecting factors such as inflammation, energy metabolism, and fat storage. The targeted supplementation of these probiotics is a precise method of regulating the microbiome to achieve weight-related objectives.
According to a report by United European Gastroenterology (UEG) in 2023, Gastrointestinal (GI) and liver disorders have a significant impact on the people of Europe, causing nearly one million deaths each year across all age groups. These conditions are associated with morbidity and healthcare expenses. The incidence and prevalence of many GI disorders are highest among the young and elderly, and as Europe's population ages, the disease burden is expected to increase.
The European region is home to over 332 million individuals affected by digestive disorders. In 31 countries with available data, digestive disease-related morbidity results in a loss of output equal to 0.22% of GDP, while premature mortality accounts for 0.25%. The report suggests that reducing digestive disease-related premature deaths by 25% in 2019 could have prevented productivity losses worth EURO 11.4 billion in 31 countries.
The European digestive health supplement market is influenced by the increasing awareness of the gut microbiome's role in weight regulation. The gut microbiome extracts energy from food, regulates metabolism, and stores and distributes fat. As a result, digestive health supplements, particularly those enriched with probiotics, are becoming crucial tools in addressing this awareness. Probiotics are live microorganisms, often beneficial bacteria that offer health benefits when consumed in sufficient quantities. In the context of weight regulation, specific probiotic strains have been linked to positive changes in gut microbiota composition, affecting factors such as inflammation, energy metabolism, and fat storage. The targeted supplementation of these probiotics is a precise method of regulating the microbiome to achieve weight-related objectives.
Europe Digestive Health Supplements Market Report Highlights
- The enzyme segment is anticipated to register a significant CAGR during the forecast period of 2024 to 2030. Digestive issues such as bloating, indigestion, and irritable bowel syndrome (IBS) are prevalent concerns. Enzyme supplements are designed to assist in the breakdown of nutrients, potentially alleviating digestive discomfort and improving nutrient absorption
- The liquid form is expected to grow at the fastest CAGR from 2024 to 2030. The portability of liquid formats allows for flexibility in consumption, enabling individuals to maintain their supplement regimens during hectic schedules. This convenience-driven approach contributes to consumers' perception of liquid supplements as user-friendly
- The sale of digestive health supplements through online retail stores is expected to grow at the fastest CAGR from 2024 to 2030. The increasing digitization of healthcare and wellness trends is driving Europe's online digestive health supplement market. The convenience and accessibility offered by digital platforms play a critical role in meeting the demand for digestive health supplements in the European market
- The prescribed digestive health supplements are expected to grow at the fastest CAGR from 2024 to 2030. The European market for digestive health supplements is witnessing significant growth in the prescribed segment. This growth can be attributed to the increased awareness among healthcare professionals and patients, the prevalence of digestive disorders, and the regulatory frameworks that ensure the safety and efficacy of prescribed supplements
- France is expected to grow at the fastest CAGR from 2024 to 2030. The rise of e-commerce and online platforms is significantly influencing digestive health supplement market in France. An increasing number of consumers are turning to digital channels for product information and purchases, which is driving the need for effective online marketing strategies and the availability of supplements through various e-commerce platforms
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Europe Digestive Health Supplements Market Variables & Trends
Chapter 4. Europe Digestive Health Supplements Market: Product Analysis & Estimates
Chapter 5. Europe Digestive Health Supplements Market: Form Analysis & Estimates
Chapter 6. Europe Digestive Health Supplements Market: Type Analysis & Estimates
Chapter 7. Europe Digestive Health Supplements Market: Distribution Channel Analysis & Estimates
Chapter 8. Europe Digestive Health Supplements Market: Regional Estimates & Trend Analysis
Chapter 9. Europe Digestive Health Supplements Market: Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Amway
- Bayer AG
- Pfizer, Inc.
- Herbalife International of America, Inc.
- Royal DSM
- NOW Foods
- Procter & Gamble
- Vitabiotics
- Nestle Health Science
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | January 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 4.03 Billion |
| Forecasted Market Value ( USD | $ 7.07 Billion |
| Compound Annual Growth Rate | 8.5% |
| Regions Covered | Europe |
| No. of Companies Mentioned | 9 |
